Meeting
2020 Genitourinary Cancers Symposium
Sequencing chemotherapy and surgery in upper tract urothelial cancers.
Authors
Saurabh Parasramka
University of Kentucky, Lexington, KY
Saurabh Parasramka , Alex Cook , Zin Myint , Ding Xue , Jianrong Wu , Peng Wang
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, Testicular, and Adrenal Cancers
Track
Urothelial Carcinoma,Adrenal Cancer,Penile Cancer,Prostate Cancer - Advanced,Prostate Cancer - Localized,Testicular Cancer,Urethral Cancer
Sub Track
Therapeutics
Citation
J Clin Oncol 38, 2020 (suppl 6; abstr 521)
Abstract #
521
Poster Bd #
K2
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Genitourinary Cancers Symposium
Neoadjuvant chemotherapy (NAC) versus adjuvant chemotherapy (AC) in patients with clinically node-positive upper tract urothelial cancer (UTUC) who underwent radical nephroureterectomy (RNU).
First Author: Karan Jatwani
Poster
2023 ASCO Gastrointestinal Cancers Symposium
The impact of peri-operative chemotherapy on the outcomes of patients with non-metastatic cholangiocarcinoma.
First Author: Firas Baidoun
Poster
2021 ASCO Annual Meeting
Use of circulating tumor DNA in colorectal cancer patients to assess tumor burden and response to therapy: An observational study.
First Author: Erin L. Symonds
Poster
2023 ASCO Annual Meeting
Neoadjuvant cemiplimab with platinum-doublet chemotherapy and cetuximab to de-escalate surgery and omit adjuvant radiation in locoregionally advanced head & neck squamous cell carcinoma (HNSCC).
First Author: Winston Wong